DBV Technologies to Take Part in the 2nd Annual Healthcare Innovation Conference Hosted by Guggenheim
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 04 2025
0mins
Source: Globenewswire
DBV Technologies Participation: DBV Technologies will participate in the Guggenheim 2nd Annual Healthcare Innovation Conference on November 11, 2025, with CEO Daniel Tassé featured in a fireside chat.
Company Focus: DBV Technologies is a clinical-stage biopharmaceutical company developing treatments for food allergies using its proprietary VIASKIN® patch technology, which aims to desensitize the immune system through epicutaneous immunotherapy (EPIT).
Get Free Real-Time Notifications for Any Stock
Monitor tickers like undefined with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
